| IVP 0.082 256.52% | OCG 0.0118 4.42% | SOXS 2.28 0.48% | SEGG 0.9267 79.91% | ZSL 2.82 -14.80% | MTEN 0.0353 4.75% | SLV 84.56 7.58% | SAFX 0.1373 -17.74% | NVDA 183.14 -1.44% | INTC 48.72 3.02% | ASST 1.03 6.19% | TZA 6.16 -1.99% | TQQQ 53.83 -3.18% | JTAI 0.4546 13.65% | DVLT 0.7182 -10.33% | SPY 690.36 -0.49% | PSTV 0.2904 -38.23% | BBAI 6.26 2.79% | IBIT 55.44 3.49% | ONDS 13.56 -2.38% | MSTX 5.2 7.22% | PLUG 2.35 3.07% | ROLR 18.89 436.65% | XLE 48.06 2.26% | QQQ 619.55 -1.07% | TSLL 18.07 -3.58% | BAC 52.48 -3.78% | SOXL 55.38 -1.23% | ASBP 0.0587 -26.44% | BMNR 32.68 4.68% | BITO 13.56 3.39% | TSLS 5.19 1.76% | DUST 5.8 -0.68% | AAL 15.14 -1.37% | BITF 2.94 -5.47% | FNGD 5.51 5.15% | DNN 3.49 4.33% | ACHR 8.91 5.19% | CLSK 13.34 6.29% | F 13.835 -1.04% | JDST 2.11 -0.71% | XLF 54.15 -0.15% | CRML 17.925 32.58% | BEEM 1.87 5.65% | ETHA 25.59 5.66% | TSLA 439.2 -1.79% | OPEN 6.64 -1.92% | MARA 11.11 1.46% | PBR 12.66 2.93% | SIDU 3.75 20.58%

ASML Shares Surge After Aletheia Double Upgrades Stock to Buy

Shares of ASML (NASDAQ: ASML) jumped more than 8% intraday on Friday after Aletheia Capital double upgraded the stock to Buy from Sell and sharply raised its price target.

Aletheia increased its price target to €1,250, or $1,500 per ADR, from €640, or $750, and based the new valuation on a 30x fiscal 2027 earnings multiple. The upgrade reflected significantly higher fiscal 2026 and 2027 earnings estimates, incorporating expectations for a new wave of investment expansions and semiconductor capacity upgrades.

The firm said upside catalysts included stronger-than-expected demand for extreme ultraviolet (EUV) lithography tools from DRAM manufacturers, resilient demand for deep ultraviolet (DUV) systems from China in fiscal 2026, and a potential surge in demand from TSMC in fiscal 2027.

Aletheia estimated that TSMC alone could install 40 to 45 EUV tools as it expanded advanced capacity by 40% to 50% in 2027, potentially lifting total EUV shipments to 75 to 80 units—near ASML’s maximum capacity. As a result, the firm forecast that low-NA EUV revenue would rise by roughly one-third in fiscal 2026 and accelerate by 50% to 60% in fiscal 2027, supported by higher volumes and a richer product mix.

Overall, Aletheia projected ASML’s sales growth to reach the mid-teens in fiscal 2026 and accelerate to the mid-twenties in fiscal 2027, well above both company guidance and consensus expectations.

Published on: January 2, 2026